세계의 신장 탈신경 카테터 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Renal Denervation Catheter Market Summary

The global renal denervation catheter market size was estimated at USD 84.91 million in 2025 and is projected to reach USD 453.97 million by 2033, growing at a CAGR of 23.31% from 2025 to 2033. This growth is primarily driven by the increasing global burden of hypertension, particularly treatment-resistant hypertension, which affects a significant proportion of patients who do not respond adequately to pharmacological therapy.

As a minimally invasive procedure, renal denervation (RDN) offers a promising alternative for patients seeking long-term blood pressure control with fewer medications. According to the NIH, hypertension is a critical public health issue and a leading cause of cardiovascular disease, morbidity, and premature mortality worldwide. About 1.13 billion people - one in six globally - are affected by high blood pressure, which is projected to increase to 1.5 billion by 2025.

The rising global prevalence of hypertension is a significant factor fueling the growth of the renal denervation catheter market. Hypertension remains one of the most significant modifiable risk factors for cardiovascular disease, stroke, and kidney failure, and its incidence continues to escalate due to factors such as aging populations, unhealthy lifestyles, obesity, high salt intake, and increasing levels of stress. According to the WHO, as of March 2023, approximately 1.28 billion adults aged 30 to 79 years are affected by hypertension, with two-thirds of them living in low- and middle-income countries. Particularly concerning the subset of this population is those with resistant hypertension-patients who fail to achieve target blood pressure levels despite using three or more antihypertensive medications, including a diuretic. This group represents a key renal denervation therapy target population.

As awareness of the limitations of pharmacologic treatments grows and the demand for more effective, longer-lasting interventions increases, renal denervation is gaining attention as a minimally invasive option to reduce sympathetic nerve activity and achieve sustained blood pressure control. The increasing clinical and real-world evidence supporting RDN's efficacy and safety in lowering blood pressure, especially in resistant hypertension, is driving its acceptance among physicians and patients, significantly contributing to the expansion of the renal denervation catheter market.

Global Renal Denervation Catheter Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2025 to 2033. For this study, Grand View Research has segmented the global renal denervation catheter market report based on product, end use, and region:

• Product Outlook (Revenue, USD Million, 2025 - 2033)
• Radiofrequency (RF) Ablation Catheters
• Ultrasound Ablation Catheters
• End Use Outlook (Revenue, USD Million, 2025 - 2033)
• Hospitals
• Others
• Regional Outlook (Revenue, USD Million, 2025 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Renal Denervation Catheter Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of hypertension as a leading cause of cardiovascular disease
    • 3.2.1.2. Growing regulatory approvals
    • 3.2.1.3. Increasing awareness about hypertension management
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Potential adverse events and complications associated with renal denervation catheters
    • 3.2.2.2. Shortage of cardiologists
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Growing clinical trials for renal denervation catheters
    • 3.2.3.2. Improving reimbursement for renal denervation catheters
    • 3.2.3.3. Strategic investments for renal denervation product portfolio expansion
    • 3.2.3.4. Expansion potential in emerging economies
    • 3.2.3.5. Advancing multielectrode RDN catheters with dual access capabilities
  • 3.2.4. Market Challenges Analysis
    • 3.2.4.1. Stringent regulations
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Renal Denervation Catheter Market: Product Business Analysis

• 4.1. Product Market Share, 2025 & 2033
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 20225 to 2033 (USD Million)
• 4.4. Radiofrequency (RF) Ablation Catheters
  • 4.4.1. Radiofrequency (RF) Ablation Catheters Market, 2025 - 2033 (USD Million)
• 4.5. Ultrasound Ablation Catheters
  • 4.5.1. Ultrasound Ablation Catheters Market, 2025 - 2033 (USD Million)

Chapter 5. Renal Denervation Catheter Market: End Use Business Analysis

• 5.1. End Use Market Share, 2025 & 2033
• 5.2. End Use Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2025 to 2033 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals Market, 2025 - 2033 (USD Million)
• 5.5. Others
  • 5.5.1. Others Market, 2025 - 2033 (USD Million)

Chapter 6. Renal Denervation Catheter Market: Regional Estimates & Trend Analysis by Product, and by End Use

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2025 to 2033:
• 6.4. North America
  • 6.4.1. North America Renal Denervation Catheter Market Estimates And Forecasts, By Country, 2025 - 2033 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Mexico Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Renal Denervation Catheter Market Estimates And Forecasts, By Country, 2025 - 2033 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.5.7. Norway
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Norway Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Denmark Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.5.9. Sweden
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Sweden Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Renal Denervation Catheter Market Estimates And Forecasts, By Country, 2025 - 2033 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. South Korea Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. Australia Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Thailand Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Renal Denervation Catheter Market Estimates And Forecasts, By Country, 2025 - 2033 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA Renal Denervation Catheter Market Estimates And Forecasts, By Country, 2025 - 2033 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait Renal Denervation Catheter Market Estimates And Forecasts, 2025 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Recor Medical, Inc. (Otsuka Medical Devices Co., Ltd.)
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Medtronic
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Boston Scientific Corporation
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Shanghai Bio-heart Biological Technology Co., Ltd.
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. MicroPort Scientific Corporation
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. EnligHTN, ST. JUDE MEDICAL (Abbott Laboratories)
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Suzhou Xinmai Medical Technology Co., Ltd.
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Ablative Solutions, Inc.
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives